Company: IONQ
Filing Date: 2025-11-10
Form Type: 424B7
Source: 0000950142-25-002919
Chunk: 5

Company: IonQ, Inc.
Filing Date: 2025-11-10
Form: 424B7
Chunk 5
---
<div align='center'>RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before making a decision to invest in our securities, in addition to carefully considering the other information contained in this prospectus supplement, in the accompanying prospectus and in the documents incorporated by reference herein or therein, you should carefully consider the risks described below, as well as the risks discussed under the caption “Risk Factors” contained in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, each as amended or updated by our subsequent filings with the SEC, which are incorporated by reference into this prospectus supplement in their entirety. The risks described in these documents are not the only ones we face. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could harm our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations or prospects could be harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. Please also read carefully the section below titled “Forward-Looking Statements.”

Additional Risks Related to the Offering

Future sales or issuances of our
common stock in the public markets, including sales by the selling stockholder and our directors and officers, or the perception of such
sales, could depress the trading price of our common stock.

The sale of a substantial number of shares of
our common stock or other equity-related securities in the public markets, or the perception that such sales could occur, could depress
the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. The selling
stockholder may sell large quantities of our common stock at any time pursuant to this prospectus supplement or in one or more separate
offerings. Our directors and officers are not subject to any “lock-up” or other agreements restricting them from selling shares
of common stock during or in connection with the offer and sale of shares of our common stock pursuant to this prospectus supplement,
and accordingly, subject to securities law restrictions, our directors and officers may sell shares of our common stock at any time. We
cannot predict the effect that future sales of our common stock or other equity-related securities, including by our directors and officers,
or the effect that the timing of